arGEN-X Company Profile

06:01 EDT 22nd September 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

arGEN-X Expands its Therapeutic Antibody Alliance With Shire

BREDA, the Netherlands, January 7, 2013 /PRNewswire/ -- New Discovery Program Initiated Within 12 Months Of Collaboration Start arGEN-X, a biopharmaceutical company specialized in the discovery and ...

arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology

BREDA, The Netherlands and GHENT, Belgium, March 25, 2013 /PRNewswire/ -- ARGX-112 targets IL22R1, a novel target involved in chronic skin inflammation arGEN-X, a clinical stage biopharmaceutical co...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "arGEN-X" on BioPortfolio

We have published hundreds of arGEN-X news stories on BioPortfolio along with dozens of arGEN-X Clinical Trials and PubMed Articles about arGEN-X for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of arGEN-X Companies in our database. You can also find out about relevant arGEN-X Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record